查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943474

經經皮二氧化碳監測市場按產品類型、技術、年齡層、應用和最終用戶分類的全球預測（2026-2032年）

Transcutaneous CO2 Monitoring Market by Product Type, Technology, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，經皮二氧化碳監測市場價值將達到 23.3 億美元，到 2026 年將成長至 25.4 億美元，到 2032 年將達到 40.6 億美元，複合年成長率為 8.21%。

關鍵市場統計數據
基準年 2025 23.3億美元
預計年份：2026年 25.4億美元
預測年份 2032 40.6億美元
複合年成長率 (%) 8.21%

權威概述了連續非侵入性經皮二氧化碳監測如何改變各種醫療保健環境中的呼吸照護路徑和臨床決策。

經皮二氧化碳監測正在迅速改變呼吸系統和重症監護的診療路徑，它能夠在床邊及其他場所實現對二氧化碳變化趨勢的連續、非侵入性評估。臨床醫生越來越依賴可靠的經皮感測器來補充動脈和毛細血管血氣分析，尤其是在連續有創採樣不切實際或風險較高的情況下。在包括門診手術中心、家庭護理和重症監護醫院在內的越來越多的醫療服務場所，無需重複穿刺即可獲得連續二氧化碳數據的能力有助於改善臨床決策，支持通訊協定的通氣管理，並改善鎮靜和康復期間的監測。

感測器小型化、遠端醫療整合和數據分析相結合，將經皮二氧化碳監測的應用範圍擴展到了傳統急性護理之外。

在技​​術成熟、醫療服務模式演變和數據驅動型臨床實踐的推動下，經經皮二氧化碳監測領域正在發生多項變革性變化，重塑其格局。首先，小型化和感測器技術的創新加速了攜帶式手持設備和超薄探頭的研發，使得監測範圍不再局限於加護病房和居家醫療等其他醫療環境。因此，臨床醫生能夠持續追蹤患者的通氣狀態，這在以往的心肺復健、門診監測和術後恢復期間是難以實現的。

評估2025年美國關稅調整對經皮二氧化碳監測設備製造商的零件採購、定價策略和供應鏈韌性的影響

2025年生效的關稅調整對美國醫療設備供應鏈的累積影響，將對經皮二氧化碳監測系統的製造商和採購商帶來即時的營運挑戰和長期的策略影響。關稅可能增加進口零件（例如感測器膜、電子模組和光學元件）的到岸成本，迫使原始設備製造商 (OEM) 重新評估其籌資策略，並在採購慣例中增強抵禦關稅衝擊的能力。為此，許多設備製造商正在調整材料清單(BOM) 策略，在低關稅地區尋找替代供應商，或加速本地組裝以降低進口關稅風險。

綜合細分分析揭示了最終用戶環境、患者年齡、技術類型、臨床應用和產品形式如何相互作用，從而影響設備需求。

經皮二氧化碳監測市場的細緻細分突顯了臨床需求、設備外形和技術選擇相互交織，從而形成差異化需求。分析終端使用者可知，門診手術中心需要針對快速設定和術中監測進行最佳化的設備。同時，診所包括注重常規評估的全科診所和需要高精度監測以應用於呼吸和睡眠醫學領域的專科診所。居家醫療分為兩類：上門護理服務優先考慮功能強大且易於使用的監測器，而遠端監測服務則優先考慮安全的資料傳輸和使用者友善的介面。醫院內部的需求各不相同，二級醫療機構優先考慮成本效益和工作流程整合，而三級醫療機構則需要適用於複雜重症監護和手術全期環境的高級功能。

報銷模式、基礎設施成熟度和本地生產等因素影響著主要全球市場的採用路徑，區域趨勢的比較分析也印證了這一點。

區域趨勢在經皮二氧化碳監測技術的應用和商業化過程中發揮著至關重要的作用，每個主要區域都存在不同的促進因素和限制因素。在美洲，成熟的醫院系統以及不斷擴展的門診和居家醫療服務推動了對高階主機和攜帶式手持設備的需求。報銷機制和大規模採購計畫影響著採購週期，而完善的服務基礎設施則為設備的長期維護和培訓提供了支援。歐洲、中東和非洲地區的情況則較為複雜，有些國家擁有先進的三級醫療中心，而有些國家則資源有限，這使得對高階光學解決方案和經濟高效的電化學解決方案的需求都日益成長。監管協調工作和跨區域報銷舉措會影響設備的核准時間和跨境分銷策略。

在連續二氧化碳監測領域，策略性產業趨勢和能力投資如何區分市場領導、新參與企業和生態系統合作夥伴。

為了確保臨床應用和商業性可行性，經經皮二氧化碳監測領域的企業正在採取多種策略，從專注於產品創新到建立生態系統夥伴關係。成熟的醫療設備製造商正致力於改進感測器化學成分和校準演算法，以提高精度並降低維護成本。同時，新參與企業則專注於便攜性、簡化的使用者介面以及雲端遠端監測，以搶佔門診和居家醫療市場。設備製造商、軟體供應商和臨床網路之間的策略聯盟，正在實現與電子健康記錄和遠端監測平台的無縫資料整合，從而提升多學科醫療團隊對持續二氧化碳監測的效用。

為製造商和供應商提供切實可行的高影響力措施，以加速監測解決方案的採用，降低供應風險，並展現其臨床和經濟價值。

在瞬息萬變的商業環境中，產業領導者應採取一系列切實有效且影響深遠的措施，以加速技術應用並保障利潤率。製造商應優先考慮與電子健康記錄和遠端監測平台的互通性和無縫資料交換，使連續二氧化碳資料成為臨床互通性中可利用的一部分，而非孤立的資料流。同時，投資於完善的售後服務，例如遠端校準、技術人員認證和臨床培訓，將有助於減少設備停機時間，並提升醫院採購團隊對設備價值的認知。

為了確保研究結果的可靠性和實際相關性，我們採用了一種透明、多方面的研究途徑，結合了臨床醫生訪談、設備文件和技術檢驗。

本研究採用結構化的調查方法，整合了多種證據來源，以確保分析的嚴謹性和實用性。主要研究包括對新生兒、兒童和成人重症監護室的臨床醫生、醫院和門診手術中心的採購人員以及參與設備整合和遠端監測操作的技術專家進行深度訪談。次要研究整合了同行評審的臨床研究、設備監管文件、臨床實踐指南和已發布的技術規範，以檢驗設備的性能特徵和臨床應用案例。

本文簡要概述了為何整合技術、臨床證據和穩健的商業策略對於連續經皮二氧化碳監測的廣泛應用至關重要。

總之，經皮二氧化碳監測正處於一個轉折點，技術的成熟、多樣化的醫療服務模式以及數據驅動的臨床工作流程的整合，將推動其在所有醫療環境中發揮更廣泛的作用。兼具準確性、易用性和連接性的設備將透過在新生兒病房、重症監護室、門診和居家照護中實現連續呼吸監測，從而最大限度地發揮其臨床價值。電化學和光學技術的融合正在創造出豐富的產品選擇，這些產品可根據特定臨床領域進行客製化，從對成本敏感的二級醫療中心到高度緊急的三級醫療中心均可適用。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 經經皮二氧化碳監測市場（依產品類型分類）

  • 監控主機
  • 攜帶式設備
  • 感測器探頭

第九經皮經皮二氧化碳監測市場（依技術分類）

  • 電化學公式
  • 光學的

第十經皮依年齡層別分類的經皮二氧化碳監測市場

  • 成人
  • 新生
  • 兒童

第11章 經經皮二氧化碳監測市場（依應用領域分類）

  • 門診監測
    • 心肺復健
    • 門診監測
  • 重症監護
    • 成人重症監護
    • 新生兒重症監護
    • 兒童重症監護
  • 新生兒護理
    • 早產兒護理
    • 足月新生兒護理
  • 呼吸護理
    • 急性呼吸護理
    • 慢性呼吸護理

第12章 經經皮二氧化碳監測市場（依最終用戶分類）

  • 門診手術中心
  • 診所
    • 一般診所
    • 專科診所
  • 居家醫療
    • 居家照護服務
    • 遠端監控服務
  • 醫院
    • 二級護理醫院
    • 三級醫院

第13章 經經皮二氧化碳監測市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章經皮二氧化碳監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五經皮各國經皮二氧化碳監測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國經皮二氧化碳監測市場

第17章：中國經皮二氧化碳監測市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Dragerwerk AG & Co. KGaA
  • General Electric Company
  • Koninklijke Philips NV
  • Laike Biotechnology Co., Ltd.
  • Masimo Corporation
  • Medicap GmbH
  • Medtronic plc
  • Mindray DS USA, Inc.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Perimed AB
  • Philips Healthcare
  • Qiumanshi Medical Technology Co., Ltd.
  • Radiometer A/S
  • Sentec AG
  • Shinsei Electronics Corporation
  • Smiths Group plc
  • Welch Allyn Inc.
Product Code: MRR-F847BD9C7378

The Transcutaneous CO2 Monitoring Market was valued at USD 2.33 billion in 2025 and is projected to grow to USD 2.54 billion in 2026, with a CAGR of 8.21%, reaching USD 4.06 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.33 billion
Estimated Year [2026] USD 2.54 billion
Forecast Year [2032] USD 4.06 billion
CAGR (%) 8.21%

An authoritative overview of how continuous noninvasive transcutaneous CO2 monitoring is changing respiratory care pathways and clinical decision-making across settings

Transcutaneous CO2 monitoring is rapidly reshaping respiratory and critical care pathways by enabling continuous, noninvasive assessment of carbon dioxide trends at the bedside and beyond. Clinicians increasingly rely on reliable transcutaneous sensors to complement arterial and capillary measurements, especially when serial invasive sampling is impractical or poses risk. As healthcare delivery diversifies across ambulatory surgery centers, home settings, and high-acuity hospitals, the capability to obtain continuous CO2 data without repeated punctures enhances clinical decision-making, supports protocolized ventilation management, and improves monitoring during sedation and rehabilitation.

The integration of portable handheld devices and sensor probes alongside conventional monitor consoles affords care teams greater flexibility in deploying monitoring where it is most needed. Concurrently, improvements in sensor chemistry, signal processing algorithms, and device ergonomics are reducing calibration burdens and increasing measurement stability across patient populations from neonates to adults. These advances, paired with evolving clinical guidelines that emphasize early detection of ventilatory compromise, are repositioning transcutaneous CO2 monitoring from a niche adjunct to a mainstream component of respiratory care pathways.

Looking ahead, the field will continue to be shaped by interoperability requirements, reimbursement clarity, and evidence that demonstrates patient-centered benefits. Clinicians and procurement leaders should therefore consider not only the technical performance of devices but also integration into care workflows, remote monitoring capabilities, and training programs that ensure reliable capture and interpretation of transcutaneous CO2 data.

How sensor miniaturization, remote care integration, and data analytics are converging to expand continuous transcutaneous CO2 monitoring beyond traditional acute care

Several transformative shifts are redefining the landscape of transcutaneous CO2 monitoring, driven by technology maturation, care delivery evolution, and data-driven clinical practice. First, miniaturization and sensor innovation have accelerated the development of portable handheld units and low-profile probes that expand monitoring beyond intensive care units into ambulatory monitoring and home healthcare environments. As a result, clinicians can track ventilatory status during cardiopulmonary rehabilitation, outpatient monitoring, and post-procedural recovery with a continuity that was previously difficult to achieve.

Second, telemonitoring and remote care models are integrating continuous physiologic inputs into virtual care pathways, enabling earlier detection of respiratory deterioration and smoother transitions from hospital to home. Third, the adoption curve for advanced monitoring is being supported by improvements in optical and electrochemical technologies that offer complementary trade-offs: optical methods often provide faster response and longer-term stability while electrochemical approaches deliver cost-effective solutions suitable for disposable or semi-disposable probes. These technical differences are influencing procurement decisions and clinical training priorities.

Finally, the convergence of data analytics, device interoperability, and clinical protocols is producing higher-value outputs from continuous CO2 traces. Predictive analytics and trend-based alerts are moving from experimental to operational status, helping care teams act on subtle physiology changes before overt clinical decline. Collectively, these shifts are expanding the clinical utility of transcutaneous CO2 monitoring and redefining expectations for continuous respiratory surveillance across the care continuum.

Assessing how 2025 US tariff adjustments are reshaping component sourcing, pricing strategies, and supply resilience for transcutaneous CO2 monitoring device manufacturers

The cumulative impact of tariff changes on medical device supply chains in the United States during 2025 introduces both immediate operational challenges and longer-term strategic repercussions for manufacturers and buyers of transcutaneous CO2 monitoring systems. Tariffs can increase landed costs for imported components such as sensor membranes, electronic modules, and optical elements, prompting original equipment manufacturers to evaluate sourcing strategies and build resilience into procurement practices. In response, many device makers are adjusting bill-of-materials strategies, seeking alternative suppliers in lower-tariff jurisdictions, or accelerating localization of assembly to reduce exposure to import duties.

For distributors and healthcare purchasers, tariff-driven cost pressure is influencing contract negotiations, total cost of ownership assessments, and capital allocation decisions. Procurement teams are under renewed scrutiny to justify purchases by demonstrating clinical value and lifecycle costs, including maintenance and consumable replacement. Meanwhile, research and development timelines may be affected as companies balance investment in next-generation optical or electrochemical sensor platforms with the need to protect margin under shifting trade conditions.

Importantly, tariff impacts extend beyond direct cost increases; they alter supplier competitiveness and can catalyze consolidation as smaller manufacturers struggle with margin compression. Stakeholders should therefore undertake scenario planning that considers alternative sourcing, multi-tier supplier relationships, and the potential for strategic partnerships that mitigate tariff exposure while preserving supply continuity and product innovation.

Integrative segmentation analysis revealing how end-user environments, patient age, technology types, clinical applications, and product formats interact to shape device requirements

Nuanced segmentation of the transcutaneous CO2 monitoring market provides clarity on where clinical demand, device form factors, and technology choices intersect to create differentiated needs. When examining end users, ambulatory surgery centers require devices optimized for rapid setup and procedure-level monitoring, while clinics encompass both general clinics that focus on routine assessment and specialty clinics that demand higher precision for pulmonary and sleep medicine applications. Home healthcare splits into home nursing services that prioritize robust, easy-to-use monitors and telemonitoring services that emphasize secure data transmission and user-friendly interfaces. Hospitals present a spectrum of requirements with secondary care hospitals prioritizing cost-effectiveness and workflow integration, and tertiary care hospitals seeking advanced features suitable for complex critical care and perioperative environments.

Age-based segmentation further refines device selection and clinical protocols, as adults, pediatrics, and neonates present different physiologic ranges, skin properties, and size constraints that influence sensor design and calibration needs. Technology segmentation, divided between electrochemical and optical approaches, highlights trade-offs in response time, calibration frequency, and consumable usage, which in turn affects procurement of monitor consoles, portable handheld devices, and sensor probes. Application-driven segmentation reveals that ambulatory monitoring includes cardiopulmonary rehabilitation and outpatient monitoring contexts where mobility and ease of use are paramount, while intensive care spans adult, neonatal, and pediatric intensive care settings that demand high-fidelity continuous measurements. Neonatal care itself splits into preterm and term neonatal care with specialized probe designs and gentle adhesive systems, and respiratory care includes acute and chronic pathways where trending capability and alarm integration are critical.

Product-type segmentation clarifies that monitor consoles typically serve centralized monitoring in hospitals, portable handheld devices support point-of-care and home settings, and sensor probes function as both disposable and reusable interfaces that determine recurring supply chain dynamics. Taken together, these segmentation layers inform clinical adoption strategies, regulatory focus, and go-to-market approaches by aligning device attributes with the operational realities and clinical endpoints of each subsegment.

Comparative regional dynamics showing how reimbursement models, infrastructure maturity, and local manufacturing shape adoption pathways across major global markets

Regional dynamics play a determinative role in how transcutaneous CO2 monitoring technologies are adopted and commercialized, with each major geography exhibiting distinct drivers and constraints. In the Americas, established hospital systems and growing outpatient and home care services drive demand for both high-end monitor consoles and portable handheld devices; reimbursement frameworks and large-scale procurement programs shape purchasing cycles while a strong service infrastructure supports long-term device maintenance and training. Europe, the Middle East & Africa presents a heterogeneous landscape where advanced tertiary centers in some countries coexist with resource-constrained facilities elsewhere, creating demand for both premium optical solutions and cost-effective electrochemical options. Regulatory harmonization efforts and pan-regional reimbursement initiatives influence device certification timelines and cross-border distribution strategies.

Asia-Pacific encompasses rapidly expanding healthcare capacity, rising investments in neonatal and critical care, and a surge in telemonitoring deployments that favor portable form factors and integrated data platforms. Local manufacturing hubs and component suppliers in this region offer opportunities for cost optimization and faster time-to-market, but also introduce competitive pressures from nimble regional entrants. Across all regions, clinical evidence generation, interoperability standards, and training programs are pivotal to scaling adoption. Stakeholders should therefore tailor commercial models to regional reimbursement structures, procurement behaviors, and clinical needs while maintaining a unified product narrative that emphasizes patient safety, usability, and data integrity.

Strategic industry maneuvers and capability investments that distinguish market leaders, new entrants, and ecosystem partners in continuous CO2 monitoring

Companies operating in the transcutaneous CO2 monitoring space are pursuing a mix of strategies to secure clinical adoption and commercial viability, ranging from focused product innovation to ecosystem partnerships. Several established medical device firms are investing in incremental improvements to sensor chemistry and calibration algorithms to enhance accuracy and reduce maintenance burden, while newer entrants are targeting portability, user interface simplicity, and cloud-enabled telemonitoring to capture outpatient and home healthcare segments. Strategic partnerships between device manufacturers, software vendors, and clinical networks are enabling more seamless data integration with electronic health records and remote monitoring platforms, thereby increasing the utility of continuous CO2 traces for multidisciplinary care teams.

Manufacturers are also optimizing product portfolios by differentiating between monitor consoles for high-acuity settings and portable handheld units for ambulatory and home use, with sensor probes designed as either reusable modules for hospitals or single-use consumables for infection control and convenience. Supply chain strategies focus on supplier diversification and vertical integration of critical components to protect against geopolitical and tariff-related disruptions. Additionally, companies are expanding into value-added services such as training, remote calibration, and clinical decision-support algorithms to enhance stickiness with healthcare customers and create recurring revenue streams.

From a competitive standpoint, firms that combine clinical evidence generation, regulatory expertise, and scalable service models are best positioned to win tenders and form long-term relationships with health systems. Corporate strategies that emphasize interoperability, user-centered design, and lifecycle support will likely determine leadership in this evolving market.

High-impact, actionable steps for manufacturers and providers to drive adoption, reduce supply risk, and demonstrate clinical and economic value for monitoring solutions

Industry leaders should adopt a set of practical, high-impact measures to accelerate adoption and protect margin in a rapidly changing commercial environment. Manufacturers must prioritize interoperability and seamless data exchange with electronic health records and telemonitoring platforms to ensure that continuous CO2 data become an actionable part of clinical workflows rather than an isolated data stream. Concurrently, investing in robust post-sales services such as remote calibration, technician certification, and clinically oriented training will reduce device downtime and increase perceived value among hospital procurement teams.

On the sourcing front, firms should implement multi-sourcing strategies for critical components and evaluate regional assembly to mitigate tariff exposure and supply chain disruption. Product roadmaps should balance innovation in optical and electrochemical sensing with cost-conscious probe designs that address both disposable and reusable use cases. For market access, building a compelling clinical evidence base through targeted multi-center studies in neonatal and intensive care units, and real-world validation in ambulatory and home settings, will support reimbursement discussions and clinician acceptance. Finally, commercial teams should segment go-to-market approaches by end user and application, aligning sales incentives and training materials to the unique priorities of ambulatory surgery centers, clinics, home healthcare providers, and different hospital tiers.

By executing on interoperability, supply resilience, evidence generation, and service excellence, industry leaders can convert technological capability into sustainable clinical adoption and commercial returns.

A transparent, multi-source research approach combining clinician interviews, device documentation, and technical validation to ensure reliable insights and practical relevance

This research synthesized multiple sources of evidence and applied a structured methodology to ensure analytical rigor and practical relevance. Primary research included in-depth interviews with clinicians across neonatal, pediatric, and adult intensive care settings, procurement leaders from hospitals and ambulatory surgery centers, and technical specialists involved in device integration and telemonitoring operations. Secondary research incorporated peer-reviewed clinical studies, device regulatory documents, clinical practice guidelines, and publicly available technical specifications to validate performance characteristics and clinical use cases.

Data triangulation was achieved by cross-referencing qualitative insights with device performance literature and supplier disclosures, enabling a balanced view of technology trade-offs and operational implications. The analysis also incorporated an assessment of supply chain exposures, tariff scenarios, and commercial strategies obtained through interviews with industry supply chain managers and commercial leaders. Quality assurance steps involved expert review by clinical informaticians and biomedical engineers to confirm technical accuracy, and an editorial review to ensure clarity and consistency.

Limitations of the methodology include variability in data availability across regions and the evolving nature of regulatory guidance and reimbursement policies. To mitigate these constraints, the study prioritized primary stakeholder perspectives and recent clinical evidence, and employed sensitivity checks to ensure that conclusions remain robust against plausible variations in external conditions.

A concise synthesis of why integrated technology, clinical evidence, and resilient commercial strategies are essential to scale continuous transcutaneous CO2 monitoring

In summary, transcutaneous CO2 monitoring stands at an inflection point where technical maturity, diversified care delivery models, and data-enabled clinical workflows converge to expand its role across care settings. Devices that balance accuracy, ease of use, and connectivity will unlock the greatest clinical value by enabling continuous respiratory surveillance in neonatal units, intensive care environments, ambulatory contexts, and home-based care. The interplay between electrochemical and optical technologies creates a spectrum of product choices that manufacturers can tailor to specific clinical segments, from cost-sensitive secondary hospitals to high-acuity tertiary centers.

Strategic considerations such as tariff management, supplier diversification, and evidence-based market access planning are critical to sustaining innovation and commercial viability. Companies that integrate robust service offerings, prioritize interoperability, and invest in targeted clinical validation will be better positioned to influence purchasing decisions and clinician adoption. Ultimately, the pathway to wider adoption requires coordinated efforts across R&D, regulatory, clinical, and commercial functions to translate continuous CO2 signals into improved patient outcomes and operational efficiencies.

Decision-makers should therefore treat transcutaneous CO2 monitoring as a strategic capability rather than a discrete product purchase, aligning technology choices with clinical protocols, workforce competencies, and long-term care delivery goals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Transcutaneous CO2 Monitoring Market, by Product Type

  • 8.1. Monitor Console
  • 8.2. Portable Handheld Device
  • 8.3. Sensor Probe

9. Transcutaneous CO2 Monitoring Market, by Technology

  • 9.1. Electrochemical
  • 9.2. Optical

10. Transcutaneous CO2 Monitoring Market, by Age Group

  • 10.1. Adults
  • 10.2. Neonates
  • 10.3. Pediatrics

11. Transcutaneous CO2 Monitoring Market, by Application

  • 11.1. Ambulatory Monitoring
    • 11.1.1. Cardiopulmonary Rehabilitation
    • 11.1.2. Outpatient Monitoring
  • 11.2. Intensive Care
    • 11.2.1. Adult Intensive Care
    • 11.2.2. Neonatal Intensive Care
    • 11.2.3. Pediatric Intensive Care
  • 11.3. Neonatal Care
    • 11.3.1. Preterm Neonatal Care
    • 11.3.2. Term Neonatal Care
  • 11.4. Respiratory Care
    • 11.4.1. Acute Respiratory Care
    • 11.4.2. Chronic Respiratory Care

12. Transcutaneous CO2 Monitoring Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Clinics
    • 12.2.1. General Clinics
    • 12.2.2. Specialty Clinics
  • 12.3. Home Healthcare
    • 12.3.1. Home Nursing Services
    • 12.3.2. Telemonitoring Services
  • 12.4. Hospitals
    • 12.4.1. Secondary Care Hospitals
    • 12.4.2. Tertiary Care Hospitals

13. Transcutaneous CO2 Monitoring Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Transcutaneous CO2 Monitoring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Transcutaneous CO2 Monitoring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Transcutaneous CO2 Monitoring Market

17. China Transcutaneous CO2 Monitoring Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Baxter International Inc.
  • 18.6. Becton, Dickinson and Company
  • 18.7. Dragerwerk AG & Co. KGaA
  • 18.8. General Electric Company
  • 18.9. Koninklijke Philips N.V.
  • 18.10. Laike Biotechnology Co., Ltd.
  • 18.11. Masimo Corporation
  • 18.12. Medicap GmbH
  • 18.13. Medtronic plc
  • 18.14. Mindray DS USA, Inc.
  • 18.15. Nihon Kohden Corporation
  • 18.16. Nonin Medical, Inc.
  • 18.17. Perimed AB
  • 18.18. Philips Healthcare
  • 18.19. Qiumanshi Medical Technology Co., Ltd.
  • 18.20. Radiometer A/S
  • 18.21. Sentec AG
  • 18.22. Shinsei Electronics Corporation
  • 18.23. Smiths Group plc
  • 18.24. Welch Allyn Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY MONITOR CONSOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PORTABLE HANDHELD DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SENSOR PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ELECTROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CARDIOPULMONARY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY OUTPATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ADULT INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PEDIATRIC INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRETERM NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERM NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY ACUTE RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CHRONIC RESPIRATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME NURSING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TELEMONITORING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 271. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 274. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 284. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 287. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 290. NATO TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY AMBULATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY NEONATAL CARE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY RESPIRATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES TRANSCUTANEOUS CO2 MONITORING MARKET